InMed Pharmaceuticals (INM) Stock Price, News & Analysis

InMed Pharmaceuticals' stock was trading at $0.4160 at the start of the year. Since then, INM stock has decreased by 30.4% and is now trading at $0.2895.
View the best growth stocks for 2024 here.

InMed Pharmaceuticals saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 10,300 shares, a decline of 81.9% from the March 15th total of 57,000 shares. Based on an average daily volume of 263,900 shares, the short-interest ratio is currently 0.0 days.
View InMed Pharmaceuticals' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our INM earnings forecast.

InMed Pharmaceuticals Inc. (NASDAQ:INM) issued its quarterly earnings results on Tuesday, February, 13th. The company reported ($0.19) earnings per share (EPS) for the quarter. The firm had revenue of $1.24 million for the quarter. InMed Pharmaceuticals had a negative net margin of 115.76% and a negative trailing twelve-month return on equity of 54.31%.

Shares of InMed Pharmaceuticals reverse split before market open on Wednesday, September 7th 2022. The 1-25 reverse split was announced on Wednesday, September 7th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 7th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of INM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.